Detection of liver cancer serum markers and molecular analysis of metabolites based on electrochemical sensors: Combined targeted immunotherapy

Key Points

• Liver cancer serum markers show distinct profiles, indicating their utility in diagnosis and monitoring.
• Key metrics indicate that the specificity of electrochemical sensors reaches 90% in detecting these markers.
• Assessment using electrochemical sensors enables molecular analysis of metabolites linked to liver cancer progression.
• Findings highlight the promise of targeted immunotherapy in improving patient outcomes, though further validation is required.